In respect of MS, the treatment with PDE-4 inhibitor ibudilast (MN-166), that has been reported to inhibit platelet aggregation as well (202), was associated with slower progression of brain atrophy in patients with progressive MS (203). The gene discussed is PDE4A; the disease is myeloid sarcoma.